Glimikare-MSR 1mg/500mg Tablet
By Glimikare-M
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg)

Manufacturer - Nitro Cadineur
#162, 2nd Floor, Jeevan Nagar, Kilokari Ashram, NEW DELHI 122 014 India

Expires on or after
October, 2025

liver
When using Glimikare-MSR 1mg/500mg Tablet, it is important to be cautious if you have liver disease. Your doctor may need to adjust the dose of the medication. Typically, Glimikare-MSR 1mg/500mg Tablet is initially prescribed in a low dose for patients with mild to moderate liver disease. However, it is not advised for use in patients with severe liver disease. It is crucial to consult your doctor for proper guidance and monitoring when taking this medication if you have liver issues.

kidney
Caution should be taken when using Glimikare-MSR 1mg/500mg Tablet in patients with kidney disease. Dose adjustment may be necessary, and consulting your doctor is important. Avoid using this medication in severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is not safe to drink alcohol while taking Glimikare-MSR 1mg/500mg Tablet. Avoid alcohol consumption to prevent potential risks.

driving
When your blood sugar levels are too low or too high, it can impact your ability to drive safely. If you experience these symptoms, avoid driving when taking Glimikare-MSR 1mg/500mg Tablet.

pregnancy
Glimikare-MSR 1mg/500mg Tablet is not recommended during pregnancy due to potential harm shown in animal studies. Consult your doctor for a thorough evaluation of benefits versus risks before use.

breastfeeding
Caution is advised when breastfeeding while taking Glimikare-MSR 1mg/500mg Tablet as it may pose risks of toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹42
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024